About two-thirds of the patient population in rheumatoid arthritis (RA) develop anti-citrullinated protein antibodies (ACPAs), and these patients tend to exhibit more severe disease phenotypes, suggesting the inflammatory nature of citrullinated neo-epitopes.7 This evidence concerns the gene PROS1 and rheumatoid arthritis.